List Of Post By Tag

Health Tech Capital leads oversubscribed $1.5M round in MIT spinoff Tenacity.
Written by Anne DeGheest // 09 February 2016 // Angel funding, press release

Seed Round to fund sales expansion and product enhancements.

Seattle, WA – February 10, 2016.
Health Tech Capital is the lead investor in a $1.5M syndicated seed round for Tenacity, a SAAS-enabled workforce retention and productivity solution for call centers and business process outsourcers. Tenacity is a graduate of the Techstars accelerator.

Continue Reading
Metrics for a Successful Startup is Revenue & Sustainability, Not How Much Money They Have Raised!
Written by Anne DeGheest // 29 June 2014 // startups, Angel funding

Digital Health funding is exploding. Last year, startups received more than $2 billion and that amount is expected to double this year. Please check my video interview at the Digital Health Summer Summit on How the HealthTech Conference on October 14 and 15, 2014 will address the Right Impact Metrics to build sustainable companies.

Continue Reading
2013 angel funding Halo Report
Written by Anne DeGheest // 08 April 2014 // Angel funding

The Angel Resource Institute, Silicon Valley Bank and CB Insights released their angel group 2013 year in review, the Halo Report.

The Halo Report analyzes angel investment activity and trends in the United States.

Here are a couple interesting 2013 highlights:

Continue Reading
WSJ: Beware of Health IT Bubble: Not Enough ‘Actual Business Plans’
Written by Anne DeGheest // 04 February 2014 // Angel funding, digital health

Veteran VC Says Beware of Health IT Bubble: Not Enough ‘Actual Business Plans’ 

Timothy Hay from the Wall Street Journal  wrote a great article after he interviewed me.

With software executives filling out the roster at this year’s JP Morgan Healthcare Conference, and with the reported IPO plans of medical cost-transparency software provider Castlight Health at a $2 billion valuation, information-technology for the health-care industry is beginning to look nearly bulletproof as a sector. But with feverish activity and high valuations comes the danger of a bubble, said veteran investor Anne DeGheest, who was an investor and entrepreneur through the tech boom of the 1990s, and who founded Sand Hill Road firm HealthTech Capital several years ago.

Ms. DeGheest has invested extensively in medical devices and in health-related information technology, and she said she learned in the ‘90s to read the signs of an economic bubble. She sees some of those signs today, telling Venture Capital Dispatch of a potential “Series B crunch” as a number of health entrepreneurs without solid business plans try to raise money from investors.

Continue Reading
New SEC Rules Could Kill Angel Investing, Hurt Startups, and Hinder Job Growth
Written by Anne DeGheest // 16 July 2013 // Angel funding

Last week the Securities and Exchange Commission approved two rules and one proposed rule that will change how entrepreneurs raise angel capital and may make investment more difficult for angels and startups alike. We think fewer angels will invest as a result, unfortunately hurting the startups that create jobs throughout the U.S.   The issues are complex, but here is a quick summary:  

Final rules ending the ban on general solicitation for companies seeking investment from accredited investors eliminates the ability of angels to self-certify their status, and will result in many angels refusing to participate in this type of investing, according to the Angel Capital Association (ACA). “With thousands fewer angels participating in this market, startups will have far less access to capital, the millions of jobs they create each year will disappear, and the economy will suffer,” said Marianne Hudson, executive director of ACA.  “This is the exact opposite of Congress’ intent in its near-unanimous passage of the JOBS Act.” Under the JOBS Act, the Securities and Exchange Commission was tasked with lifting the ban on general solicitation for issuers privately raising capital under Regulation D Rule 506(c), provided that issuers take “reasonable steps to verify” that all investors are accredited. In final rules published last week, the SEC provided a convoluted, “principles-based approach,” along with several “safe harbors” that issuers may use.  Safe harbors include:  “reviewing pay stubs for the two most recent years and current year;” or “reviewing copies of any IRS form that reports income,” (including Form W-2, Form 1099 or a copy of filed Form 1040).

Continue Reading


© 2011 HealthTech Capital. All Rights Reserved. Designed by Night River